This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gonbert, S. Articles by Thillet, J. Search for Related Content PubMed PubMed Citation Articles by Gonbert, S. Articles by Thillet, J. Related Collections Other arteriosclerosis Lipid and lipoprotein metabolism

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1353.)
© 2001 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Molecular Analysis of Apo(a) Fragmentation in Polygenic Hypercholesterolemia

Characterization of a New Plasma Fragment Pattern

Sophie Gonbert; Bruno Saint-Jore; Philippe Giral; Chantal Doucet; John Chapman; Joëlle Thillet

From the Institut National de la Santé et de la Recherche Medicale (S.G., B.S.-J., C.D., J.C., J.T.), Unité 321, and Service d’Endocrinologie et Métabolisme (P.G.), Hôpital de la Pitié, Paris, France.

Correspondence to Dr Joëlle Thillet, Institut National de la Santé et de la Recherche Medicale, Unité 321, Hô pital de la Pitié, 83 Boulevard de l’Hôpital, 75651 Paris Cedex 13, France. E-mail thillet{at}ext.jussieu.fr

Abstract—— Hypercholesterolemia is frequently associated with elevated Lp(a) levels, an independent risk factor for coronary, cerebrovascular, and peripheral vascular disease. A portion of apolipoprotein(a) [apo(a)] circulates as a series of fragments derived from the N-terminal region of apo(a). The relationship of elevated lipoprotein(a) [Lp(a)] levels to those of circulating apo(a) fragments in polygenic hypercholesterolemia is indeterminate. Therefore, plasma Lp(a) and plasma and urinary apo(a) fragment levels were measured by ELISA in 82 patients with polygenic type IIa hypercholesterolemia (low density lipoprotein cholesterol 4.13 mmol/L and triglycerides <2.24 mmol/L) and in 90 normolipidemic subjects. Lp(a) levels were significantly elevated in patients compared with control subjects (0.35±0.4 and 0.24±0.31 mg/mL, respectively; median 0.13 and 0.11 mg/mL, respectively; P=0.039), although apo(a) isoform distribution did not differ. Patients displayed significantly higher plasma and urinary apo(a) fragment levels than did control subjects (respective values were as follows: 4.97±5.51 and 2.15±2.57 [median 2.85 and 1.17] µg/mL in plasma, P<0.0001; 75±86 and 40±57 [median 38 and 17] ng/mg urinary creatinine in urine, P<0.0001). The ratio of plasma apo(a) fragments to Lp(a) levels was also significantly higher in patients than in control subjects (1.93±1.5% and 1.75±2.36%, respectively; P<0.0001). We conclude that increased plasma Lp(a) levels in polygenic hypercholesterolemia are associated with elevated circulating levels of apo(a) fragments but that this increase is not due to decreased renal clearance of apo(a) fragments. Furthermore, we identified a new pattern of apo(a) fragmentation characterized by the predominance of a fragment band whose size was related to that of the parent apo(a) isoform and that was superimposed on the series of fragments described previously by Mooser et al (J Clin Invest. 1996; 98:2414–2424). This new pattern was associated with small apo(a) isoforms and did not discriminate between hypercholesterolemic and normal subjects. However, this new apo(a) fragment pattern may constitute a novel marker for cardiovascular risk.

Key Words: hypercholesterolemia • apo(a) • vascular disease • Lp(a)